Home Biomarkers APO B : APO A Ratio

APO B : APO A Ratio

Cardiac profile Biomarker

Sample Needed

Collection Type: Blood

Body System

Related System: Cardiac profile

Overview

The APO B APO A (ApoB/ApoA1) ratio is the proportion of apolipoprotein B (the main protein on atherogenic particles such as LDL and VLDL) to apolipoprotein A‑I (the principal protein of protective HDL particles). The test measures circulating ApoB and ApoA1 concentrations and calculates their ratio to estimate the balance between atherogenic and anti‑atherogenic lipoproteins. An elevated ratio indicates a higher burden of cholesterol‑carrying particles that promote atherosclerosis and is used to assess cardiovascular disease (CVD) risk (coronary artery disease, stroke). Testing is considered when there are symptoms or signs suggestive of ischemic heart disease (chest pain, exertional dyspnea), strong family history of premature CVD, or abnormal routine lipid tests. Ratio values tend to rise with age, are usually higher in men than premenopausal women, increase after menopause, and are influenced by ethnicity, obesity, diabetes and smoking.

People also test for

Test Preparation

No special preparation is required

Why Do I Need This Test

Profile: Cardiac profile / advanced lipid testing.
Symptoms: chest pain, unexplained exertional symptoms, recurrent angina, or abnormal routine lipid panel.
Conditions: assesses risk/monitors coronary artery disease, atherosclerosis, metabolic syndrome and dyslipidemia.
Reasons for abnormal levels: high ApoB (many LDL/VLDL particles), low ApoA1 (low HDL), or both.
Biological meaning: higher ratio = greater atherogenic particle burden and higher CVD risk; lower ratio = more protective lipid profile.
Lifestyle/family: poor diet, obesity, physical inactivity, smoking, high alcohol intake, uncontrolled diabetes; positive family history of premature CVD warrants testing.

Run our symptom checker to see if this test is right for you

Symptom Checker

Understanding Test Results

ApoB/ApoA1 is unitless.
Lower ratios indicate relatively more HDL protection versus atherogenic particles.
General interpretation: <0.6 low cardiovascular risk; 0.6–0.9 (men) or 0.6–0.8 (women) moderate/intermediate risk; 0.9–1.2 high risk; >1.2 very high risk for atherosclerotic cardiovascular disease.
Elevated ratios result from raised ApoB (increased LDL, VLDL particle number, high triglycerides) or reduced ApoA1 (low HDL), and are associated with greater risk of coronary events and stroke.
Low ratios can reflect high ApoA1 or low ApoB and indicate lower risk.
Use results together with full lipid panel, clinical risk factors and age/sex; borderline or high ratios usually prompt lifestyle modification and consideration of lipid‑lowering therapy.
Laboratory methods and cutoffs vary, so interpret in clinical context.

Normal Range

Men: <0.9 (ratio); Women: <0.8 (ratio)

FAQs

Q: What is the apolipoprotein B A1 ratio test?

A: The apolipoprotein B/A1 ratio test is a blood test measuring apolipoprotein B (on atherogenic lipoproteins such as LDL and VLDL) relative to apolipoprotein A1 (the main protein in protective HDL). A higher ratio indicates greater cardiovascular risk. It refines heart‑disease risk assessment beyond traditional cholesterol tests and can help guide prevention or treatment decisions.

Q: What is a normal apoB range?

A: Generally, apolipoprotein B (ApoB) is considered optimal at under 90 mg/dL (0.90 g/L). Levels around 90–119 mg/dL are intermediate or borderline, while ≥120 mg/dL indicates higher cardiovascular risk. For people at very high risk, many guidelines aim for lower targets—often below 70–80 mg/dL. Check with your clinician for personalized targets and interpretation.

Q: What are ApoA and apoB?

A: Apolipoprotein A (mainly ApoA‑I) is the primary protein of HDL particles, promoting reverse cholesterol transport from tissues to the liver and protecting against atherosclerosis. Apolipoprotein B (mainly ApoB‑100) is the main protein of atherogenic lipoproteins (LDL, VLDL), required for cholesterol delivery to tissues; higher apoB reflects more atherogenic particles and greater cardiovascular risk.

Q: How to lower apoB apo A1 ratio?

A: Lower the apoB/apoA1 ratio by reducing ApoB and raising ApoA1: adopt a heart‑healthy diet (cut saturated/trans fats, eat more unsaturated fats, soluble fiber, omega‑3s), lose weight, exercise ≥150 minutes/week, stop smoking, control blood sugar and blood pressure, and limit alcohol. When needed, take prescribed lipid‑lowering drugs (statins, ezetimibe, PCSK9 inhibitors) and get regular lab monitoring.

Q: What is a good Apo A to apoB ratio?

A: A healthy ApoA:ApoB ratio is generally above 1.0; higher is better. Many guidelines consider about ≥1.1 for men and ≥1.25 for women to be optimal. Lower ratios indicate relatively more atherogenic (ApoB-containing) particles and higher cardiovascular risk. Interpret results with other risk factors and discuss treatment or lifestyle changes with your clinician.

Q: How to reduce apoB naturally?

A: Lower apoB naturally by improving diet and lifestyle: lose excess weight; replace saturated/trans fats with unsaturated fats (olive oil, nuts, avocados) and eat fatty fish for omega‑3s; increase soluble fiber (oats, legumes, psyllium) and plant sterols; limit refined carbs, added sugars and processed foods; do regular aerobic exercise (≥150 min/week), quit smoking, limit alcohol, and control blood sugar and thyroid health with medical follow‑up.